US Bancorp
IART icon

US Bancorp’s Integra LifeSciences IART Stock Holding History

US Bancorp’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75K Sell
717
-2,044
-74% -$22.4K ﹤0.01% 3483
2025
Q4 		$34.3K Sell
2,761
-383
-12% -$5.09K ﹤0.01% 2856
2025
Q3 		$45.1K Buy
3,144
+1,088
+53% +$14.9K ﹤0.01% 2725
2025
Q2 		$25.2K Sell
2,056
-1,523
-43% -$22.1K ﹤0.01% 3087
2025
Q1 		$78.7K Buy
3,579
+478
+15% +$11.2K ﹤0.01% 2498
2024
Q4 		$70.3K Buy
3,101
+250
+9% +$5.46K ﹤0.01% 2570
2024
Q3 		$51.8K Buy
2,851
+396
+16% +$9.18K ﹤0.01% 2722
2024
Q2 		$71.5K Buy
2,455
+387
+19% +$11.5K ﹤0.01% 2494
2024
Q1 		$73.3K Sell
2,068
-261
-11% -$10.4K ﹤0.01% 2507
2023
Q4 		$101K Buy
2,329
+50
+2% +$1.97K ﹤0.01% 2353
2023
Q3 		$87K Sell
2,279
-3,726
-62% -$157K ﹤0.01% 2207
2023
Q2 		$247K Sell
6,005
-846
-12% -$40.7K ﹤0.01% 1768
2023
Q1 		$393K Sell
6,851
-222
-3% -$12.5K ﹤0.01% 1524
2022
Q4 		$397K Buy
7,073
+93
+1% +$4.73K ﹤0.01% 1515
2022
Q3 		$296K Sell
6,980
-974
-12% -$49.9K ﹤0.01% 1645
2022
Q2 		$430K Buy
7,954
+572
+8% +$34.4K ﹤0.01% 1525
2022
Q1 		$474K Sell
7,382
-143
-2% -$9.41K ﹤0.01% 1552
2021
Q4 		$504K Sell
7,525
-326
-4% -$22.1K ﹤0.01% 1520
2021
Q3 		$539K Sell
7,851
-12
-0.2% -$848 ﹤0.01% 1481
2021
Q2 		$536K Sell
7,863
-2,084
-21% -$147K ﹤0.01% 1519
2021
Q1 		$688K Sell
9,947
-1,173
-11% -$79.5K ﹤0.01% 1336
2020
Q4 		$721K Sell
11,120
-1,157
-9% -$62.3K ﹤0.01% 1257
2020
Q3 		$580K Sell
12,277
-184
-1% -$8.75K ﹤0.01% 1249
2020
Q2 		$586K Buy
12,461
+2,376
+24% +$117K ﹤0.01% 1200
2020
Q1 		$451K Buy
10,085
+3,694
+58% +$194K ﹤0.01% 1258
2019
Q4 		$372K Buy
6,391
+524
+9% +$31.2K ﹤0.01% 1513
2019
Q3 		$352K Sell
5,867
-162
-3% -$9.65K ﹤0.01% 1528
2019
Q2 		$336K Sell
6,029
-419
-6% -$21.6K ﹤0.01% 1589
2019
Q1 		$359K Sell
6,448
-483
-7% -$24.6K ﹤0.01% 1543
2018
Q4 		$313K Sell
6,931
-10,138
-59% -$556K ﹤0.01% 1543
2018
Q3 		$1.12M Sell
17,069
-5,605
-25% -$348K ﹤0.01% 1045
2018
Q2 		$1.46M Sell
22,674
-3,478
-13% -$215K ﹤0.01% 930
2018
Q1 		$1.45M Sell
26,152
-1,612
-6% -$84.5K ﹤0.01% 922
2017
Q4 		$1.33M Buy
27,764
+787
+3% +$38.5K ﹤0.01% 967
2017
Q3 		$1.36M Buy
26,977
+3,357
+14% +$172K ﹤0.01% 951
2017
Q2 		$1.29M Buy
23,620
+593
+3% +$28.3K ﹤0.01% 949
2017
Q1 		$971K Buy
23,027
+22,725
+7,525% +$971K ﹤0.01% 1088
2016
Q4 		$13K Hold
302
– – ﹤0.01% 2968
2016
Q3 		$12K Hold
302
– – ﹤0.01% 2952
2016
Q2 		$12K Sell
302
-32
-10% -$1.15K ﹤0.01% 2956
2016
Q1 		$12K Sell
334
-3,502
-91% -$109K ﹤0.01% 2941
2015
Q4 		$130K Sell
3,836
-172
-4% -$5.38K ﹤0.01% 1914
2015
Q3 		$119K Sell
4,008
-941
-19% -$29.4K ﹤0.01% 1981
2015
Q2 		$136K Sell
4,949
-416
-8% -$11.1K ﹤0.01% 1957
2015
Q1 		$135K Buy
5,365
+159
+3% +$3.76K ﹤0.01% 1975
2014
Q4 		$115K Sell
5,206
-812
-13% -$16.5K ﹤0.01% 2055
2014
Q3 		$122K Sell
6,018
-7,227
-55% -$144K ﹤0.01% 2005
2014
Q2 		$255K Buy
13,245
+885
+7% +$16.5K ﹤0.01% 1684
2014
Q1 		$232K Buy
12,360
+294
+2% +$5.67K ﹤0.01% 1696
2013
Q4 		$235K Sell
12,066
-2,831
-19% -$51.9K ﹤0.01% 1640
2013
Q3 		$245K Buy
14,897
+1,718
+13% +$27.6K ﹤0.01% 1595
2013
Q2 		$198K Buy
+13,179
New +$193K ﹤0.01% 1642

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

US Bancorp's IART Position: Q1 2026 in Review

US Bancorp reduced its Integra LifeSciences (IART) stake by 74% in Q1 2026, selling an estimated $22.4K and leaving 717 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3483.

US Bancorp first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.46M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • US Bancorp held 717 shares of Integra LifeSciences worth $6.75K as of Q1 2026.
  • US Bancorp sold 2,044 Integra LifeSciences shares in Q1 2026, an estimated $22.4K.
  • Integra LifeSciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3483 holding.
  • US Bancorp first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Integra LifeSciences position peaked at $1.46M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.